A short-term plaque assay for antiviral drug research on herpes simplex virus type 2

New Microbiologica

Volumn 19, Issue 3, 1996, Pages 257-262

  Muratore, O ^a   Tonoli, E L ^a   Pesce Schito, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antiviral drug research; Herpes simplex viruses; HSV 2; short term plaque assay; Single cycle of infection

Indexed keywords

ANTIVIRUS AGENT;

ANIMAL; ARTICLE; CERCOPITHECUS; CYTOPATHOGENIC EFFECT; GROWTH, DEVELOPMENT AND AGING; HERPES SIMPLEX VIRUS 2; HUMAN; METHODOLOGY; TIME; VERO CELL; VIRUS CULTURE;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; HERPESVIRUS 2, HUMAN; HUMANS; PLAQUE ASSAY; TIME FACTORS; VERO CELLS;

EID: 0030184257     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ALBRECHT, M.A., DE LUCA, N.A., BYRN, R.A., SCHAFFER, P.A., and HAMMER, S.M. (1989). The herpes simplex virus immediate-early protein ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes. Journal of Virology 63, 1861-1868.
2. BAICHWAL, V.R., and SUGDEN, B. (1988). Latency comes of age for herpesviruses. Cell 52, 787-789.
3. nd Edition, Boston (USA).
4. DOLIN, R. (1985). Antiviral chemotherapy and chemoprophylaxis. Science 227, 1296-1303.
5. FALKE, D., KNOBLICH, A., and MULLER, S. (1985). Fusion from without induced by herpes simplex virus type 1. Intervirology 24, 211-219.
6. GAUTSCH, J.W., and MEIER, H. (1976). A short-term quantitative XC assay for murine leukemia virus. Virology 72, 509-513.
7. HEROLD, B.C., WU DUNN, D., SOLTYS, B., and SPEAR, P.G. (1991). Glycoprotein C of Herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. Journal of Virology 65, 1090-1098.
8. MURATORE, O., VARNIER, O.E., RAFFANTI, S.P., and SCHITO, G.C. (1984). In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate. European Journal of Clinical Microbiology 3, 447-449.
9. MURATORE, O. (1985). Murine retroviruses: an alternative screening approach for antiviral drug research. In: Gallo, R.C., Stehelin, D., Varnier, O.E., Eds., Retroviruses and human pathology. 85, 145-150, Humana Press, Clifton (USA).
10. MURATORE, O., PESCE SCHITO, A., MOSTI, L., SANSEBASTIANO, L., and SCHITO, G.C. (1991). S-7 inhibition of herpes simplex virus type 1 infectivity and replication in cultured cells. Journal of Chemotherapy 3, Suppl. 1, 84-85.
11. nd Symposium on "The antimicrobial agent resistances: origin, treatment and control", Montecarlo, Principality of Monaco, March 23-26, 1993, 237-241.
12. MURATORE, O., PESCE SCHITO, A., PETTA, A., and SCHITO, G.C. (1993 b). Studies to define a plaque assay which utilizes a single cycle of infection in Vero cell cultures for herpes simplex virus type 1. European Bulletin of Drug Research 2, Suppl. 1, 151-153.
13. MURATORE, O., TONOLI, E.L., PESCE SCHITO, A., SCHITO, G.C., SACCÀ, S.C., GHIGLIONE, D., and CIURLO, G. (1994). The mixed leukocyte reaction may promote the growth of human pericorneal fibroblasts in primary culture. Microbiologica 17, 141-146.
14. MURATORE, O., PESCE SCHITO, A., TONOLI, E.L., and MOSTI, L. (1995). Antiviral activity of S-7HNa on the infectivity and replication of herpes simplex virus type 1 in cultured cells. Journal of Chemotherapy 7, 30-32.
15. ROIZMAN, B., and SEARS, A.E. (1987). An inquiry into the mechanisms of herpes simplex virus latency. Ann. Rev. Microbiol., 41, 543-71.
16. SAFRIN, S., ELBEIK, T., and MILLS, J. (1994). A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates. Journal of Infectious Diseases 169, 879-882.
17. SANSEBASTIANO, L., MOSTI, L., SCHENONE, P., MURATORE, O., PETTA, A., DEBBIA, E.A., PESCE SCHITO, A., and SCHITO, G.C. (1993). Synthesis, antiviral (HSV-1) and antimycotic activities of ethyl or methyl 2, 4-disubstituted 5-pyrimidinecarboxylates, 2, 4-disubstituted 5-pyrimidinecarboxylic acids and 2, 4-disubstituted pyrimidines. Il Farmaco 48, 335-355.
18. SCHINAZI, R.F., FOX, J.J., WATANABE, K.A., and NAHMIAS, A.J. (1986). Activities of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5 iodocytosine and its metabolites against Herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with Herpes simplex virus type 2. Antimicrobial Agents and Chemotherapy 29, 77-84.
19. SUDO, K., KONNO, K., YOKOTA, T., and SHIGETA, S. (1994). A sensitive assay system screening antiviral compounds against herpes simplex virus type 1 and type 2. Journal of Virological Methods 49, 169-178.
20. VARNIER, O.E., MURATORE, O., RAFFANTI, S.P., MELIOLI, G., PALÙ, G., and SCHITO, G.C. (1984). Coumermycin inhibition of murine retrovirus replication in cultured cells. Journal of Antimicrobial Chemotherapy 14, 139-147.
21. VARNIER, O.E., MURATORE, O., RAFFANTI, S.P., and SCHITO, G.C. (1985). Antiviral activity of coumermycin: identification of resistant and sensitive retrovirus strains. Microbiologica 8, 283-287.
22. WALEV, I., WEISE, K., and FALKE, D. (1991). Differentiation of Herpes simplex virus-induced fusion from without and fusion from within by ciclosporin A and compound 48/80. The Journal of General Virology 72, 1377-1382.
23. rd Edition, Encino, California (USA).